Skip to main content
Mukka Proteins Limited logo

Mukka Proteins Limited — Investor Relations & Filings

Ticker · MUKKA ISIN · INE0CG401037 LEI · 3358001F6BWKSFSZ2U02 BSE.NS Manufacturing
Open in API
Filings indexed 220 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS MUKKA

About Mukka Proteins Limited

https://mukkaproteins.com/

Mukka Proteins Limited specializes in the manufacture and supply of high-quality fish meal, fish oil, and fish soluble paste. The company serves as a critical supplier to the global aquafeed, poultry feed, and pet food sectors. Its core operations involve processing raw fish into nutrient-dense protein sources and essential fatty acids, including Omega-3. The product portfolio includes steam-dried fish meal and high-grade fish oil used in specialized animal nutrition formulations. Mukka Proteins maintains a robust supply chain and utilizes advanced processing technologies to ensure product consistency and nutritional integrity. The company caters to both domestic and international markets, positioning itself as a key provider of sustainable marine protein ingredients for the livestock and aquaculture sectors.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Interim / Quarterly Report Classification · 92% confidence The document is an official disclosure under Regulation 30 and 33 of SEBI LODR relating to the Board meeting held on May 15, 2026, where the audited financial results for the quarter and year ended March 31, 2026 were approved and enclosed along with the Independent Auditor’s Report and CFO’s declaration. It includes actual financial statements (not merely a notice of publication) and is filed as the periodic quarterly (Q4) results (which in India commonly include full year numbers). This aligns with the definition of an Interim/Quarterly Report (IR) rather than a simple announcement or annual report. Therefore, the correct classification is IR. FY 2026
2026-05-15 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 78% confidence The document is the formal public filing of the Board’s approval of the audited financial results for the quarter and year ended March 31, 2026, including the CFO declaration and the full Independent Auditor’s Report. Although it begins as an “Outcome of Board Meeting” letter (covering multiple corporate actions), the bulk of the 69,508-character filing is the actual audited quarterly/year-end results and audit report itself, not merely a short notice that the report is available. Under our definitions, this constitutes a substantive interim/quarterly financial report rather than a simple announcement or purely audit‐only letter. Hence, it should be classified as an Interim/Quarterly Report (IR). FY 2026
2026-05-15 English
Please find attached.
Regulatory Filings Classification · 12% confidence The document is a combined board meeting outcome filed under SEBI LODR, including the approval and attachment of audited quarterly and annual financial results, the independent auditor’s report, and various Board approvals for fundraisings and investments. It is not a full annual report (10-K), not a simple earnings release (ER), nor solely an audit report schedule. It is a regulatory announcement for stock exchanges under Indian listing rules and does not neatly fit other specific categories, making it a general regulatory filing (RNS).
2026-05-15 English
Please find attached the outcome.
Regulatory Filings Classification · 78% confidence The document is addressed to the NSE and BSE under SEBI (Listing Obligations) Regulations and is titled “Outcome of the Board Meeting.” It outlines board approvals (audited financial results for the year/quarter, auditor’s report, CFO declaration, fund‐raising proposals, JV/investment decisions) and encloses the independent auditor’s report. This is a regulatory exchange filing announcing board decisions and attaching compliance documents rather than the full financial report itself. It does not present the complete financial statements within the text but refers to enclosures, so per the “menu vs meal” and Certification rules it is a general regulatory announcement, best classified as RNS.
2026-05-15 English
Mukka Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2026 ,inter alia, to consider and approve 1. The audited financial results ....
Regulatory Filings Classification · 82% confidence The document is a formal notice (“Intimation of Board Meeting”) under SEBI Listing Regulations informing exchanges of an upcoming Board meeting’s agenda (approval of audited results and fund raising issuance) and closure of trading window. It does not contain financial results itself, management changes, or the report text, but rather a regulatory announcement. This fits under a general regulatory filing category (Regulatory Filings, RNS).
2026-05-12 English
Agreements
Capital/Financing Update Classification · 95% confidence The document is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about the company entering into a loan agreement with its subsidiary. The content is a formal notification to stock exchanges about a material event (loan agreement) involving related parties. It does not contain financial statements, audit information, or detailed financial results. It is a regulatory announcement about a capital/financing update (loan agreement). The document length is 4197 characters, which is short and consistent with an announcement rather than a full report. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2026-04-21 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.